Mark Opler

2.0k total citations
57 papers, 1.4k citations indexed

About

Mark Opler is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Clinical Psychology. According to data from OpenAlex, Mark Opler has authored 57 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Psychiatry and Mental health, 19 papers in Experimental and Cognitive Psychology and 18 papers in Clinical Psychology. Recurrent topics in Mark Opler's work include Schizophrenia research and treatment (20 papers), Mental Health Research Topics (15 papers) and Child and Adolescent Psychosocial and Emotional Development (8 papers). Mark Opler is often cited by papers focused on Schizophrenia research and treatment (20 papers), Mental Health Research Topics (15 papers) and Child and Adolescent Psychosocial and Emotional Development (8 papers). Mark Opler collaborates with scholars based in United States, Denmark and Israel. Mark Opler's co-authors include Dolores Malaspina, James E. Gangwisch, Lawrence H. Yang, Cheryl M. Corcoran, Ahtoy J. Wonpat-Borja, Gary Zammit, Lauren Hale, Dorothy S. Lane, Martha E. Payne and Lorena García and has published in prestigious journals such as American Journal of Clinical Nutrition, JNCI Journal of the National Cancer Institute and Biological Psychiatry.

In The Last Decade

Mark Opler

54 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Opler United States 17 476 381 297 245 238 57 1.4k
Hisham Ziauddeen United Kingdom 22 243 0.5× 301 0.8× 270 0.9× 656 2.7× 280 1.2× 54 1.9k
Jack Cotter United Kingdom 20 305 0.6× 950 2.5× 147 0.5× 494 2.0× 361 1.5× 34 2.0k
Nilufar Mossaheb Austria 24 336 0.7× 919 2.4× 87 0.3× 467 1.9× 182 0.8× 72 1.8k
Alfonso Gutiérrez‐Zotes Spain 19 225 0.5× 385 1.0× 176 0.6× 289 1.2× 107 0.4× 62 1.3k
Tineke van Veen Netherlands 25 474 1.0× 330 0.9× 163 0.5× 637 2.6× 173 0.7× 47 2.2k
Kara L. Kerr United States 23 268 0.6× 349 0.9× 130 0.4× 444 1.8× 355 1.5× 47 1.4k
Seon‐Cheol Park South Korea 20 464 1.0× 376 1.0× 83 0.3× 411 1.7× 177 0.7× 123 1.5k
Abigail K. Rose United Kingdom 23 253 0.5× 205 0.5× 91 0.3× 256 1.0× 87 0.4× 63 1.3k
In‐Kwa Jung South Korea 25 175 0.4× 674 1.8× 168 0.6× 361 1.5× 124 0.5× 55 1.6k
Felipe Ortuño Spain 22 129 0.3× 401 1.1× 206 0.7× 222 0.9× 165 0.7× 59 1.3k

Countries citing papers authored by Mark Opler

Since Specialization
Citations

This map shows the geographic impact of Mark Opler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Opler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Opler more than expected).

Fields of papers citing papers by Mark Opler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Opler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Opler. The network helps show where Mark Opler may publish in the future.

Co-authorship network of co-authors of Mark Opler

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Opler. A scholar is included among the top collaborators of Mark Opler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Opler. Mark Opler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cohen, Alex S., et al.. (2025). A Single, Interpretable Vocal Biomarker for Enriching Antipsychotic Clinical Trials. Biological Psychiatry.
2.
Siegel, Joshua S., Alex S. Cohen, Steven T. Szabo, et al.. (2024). Enrichment using speech latencies improves treatment effect size in a clinical trial of bipolar depression. Psychiatry Research. 340. 116105–116105. 3 indexed citations
3.
Cohen, Alex S., Mark Opler, Brian Kirkpatrick, et al.. (2024). Evaluating speech latencies during structured psychiatric interviews as an automated objective measure of psychomotor slowing. Psychiatry Research. 340. 116104–116104. 2 indexed citations
4.
Rabinowitz, Jonathan, Mark Opler, Selam Negash, et al.. (2020). Consistency checks to improve measurement with the Personal and Social Performance Scale (PSP). Schizophrenia Research. 228. 529–533. 7 indexed citations
5.
Gangwisch, James E., Lauren Hale, Marie‐Pierre St‐Onge, et al.. (2019). High glycemic index and glycemic load diets as risk factors for insomnia: analyses from the Women’s Health Initiative. American Journal of Clinical Nutrition. 111(2). 429–439. 85 indexed citations
6.
Ghuloum, Suhaila, Ziyad Mahfoud, Mark Opler, et al.. (2017). Validation of the Five-Factor Model of the Arabic Version of the Positive and Negative Syndrome Scale in Schizophrenia. Psychopathology. 50(3). 211–218. 7 indexed citations
7.
Kirkpatrick, Brian, Jay Saoud, Gregory P. Strauss, et al.. (2017). The brief negative symptom scale (BNSS): Sensitivity to treatment effects. Schizophrenia Research. 197. 269–273. 20 indexed citations
8.
Ford, Julián D., Michaela Mendelsohn, Lewis A. Opler, et al.. (2015). The Symptoms of Trauma Scale (SOTS). Journal of Psychiatric Practice. 21(6). 474–483. 7 indexed citations
9.
Ghuloum, Suhaila, et al.. (2015). Validation of the Arabic Version of the Positive and Negative Syndrome Scale (PANSS). 2(3). 1 indexed citations
11.
Opler, Lewis A., Alice Medalia, Mark Opler, & Stephen M. Stahl. (2013). Pharmacotherapy of cognitive deficits in schizophrenia. CNS Spectrums. 19(2). 142–156. 15 indexed citations
12.
Khan, Anzalee, Jean‐Pierre Lindenmayer, Mark Opler, et al.. (2013). A new Integrated Negative Symptom structure of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia using item response analysis. Schizophrenia Research. 150(1). 185–196. 14 indexed citations
13.
Khan, Anzalee, et al.. (2012). Assessing the Sources of Unreliability (Rater, Subject, Time-Point) in a Failed Clinical Trial Using Items of the Positive and Negative Syndrome Scale (PANSS). Journal of Clinical Psychopharmacology. 33(1). 109–117. 17 indexed citations
14.
Lee, Hyejoo, Dolores Malaspina, Hongshik Ahn, et al.. (2011). Paternal age related schizophrenia (PARS): Latent subgroups detected by k-means clustering analysis. Schizophrenia Research. 128(1-3). 143–149. 31 indexed citations
15.
Jia, Hongxiao, et al.. (2011). Emotional and Neurobehavioural Status in Chronic Pain Patients. Pain Research and Management. 16(1). 41–43. 16 indexed citations
16.
Opler, Mark, Susan Harlap, Katherine Ornstein, et al.. (2010). Time-to-pregnancy and risk of schizophrenia. Schizophrenia Research. 118(1-3). 76–80. 7 indexed citations
17.
Rosenfield, Paul, Karine Kleinhaus, Mark Opler, et al.. (2009). Later paternal age and sex differences in schizophrenia symptoms. Schizophrenia Research. 116(2-3). 191–195. 23 indexed citations
18.
Malaspina, Dolores, Mary Perrin, Karine Kleinhaus, Mark Opler, & Susan Harlap. (2008). Growth and Schizophrenia: Aetiology, Epidemiology and Epigenetics. Novartis Foundation symposium. 289. 196–207. 8 indexed citations
19.
Kobak, Kenneth A., Mark Opler, & Nina Engelhardt. (2007). PANSS rater training using Internet and videoconference: Results from a pilot study. Schizophrenia Research. 92(1-3). 63–67. 15 indexed citations
20.
Opler, Lewis A., et al.. (2006). Pharmacotherapy of post-traumatic stress disorder. Drugs of today. 42(12). 803–803. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026